Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Clare Cook

Boosting Engagement with Fun: Asynchronous Touchpoints – Impetus InSite Tips for Optimizing Asynchronous Virtual Meetings

Unlock the secret to keeping participants engaged in longer asynchronous touchpoints with our sixth tip. Learn how integrating elements of fun can refresh focus and enhance interaction in virtual settings.

Impetus Digital

- PMLiVE

UK government launches five-year national action plan for antimicrobial resistance

It is estimated that 1.27 million global deaths in 2019 were caused by antibiotic-resistant infections

- PMLiVE

AstraZeneca/Sanofi reveal promising real-world data for Beyfortus in infant RSV

The treatment reduced RSV hospitalisations by 82% in infants under six months during the 2023 to 2024 RSV season

- PMLiVE

LEO Pharma shares positive phase 3 results for Enstilar in stable plaque psoriasis

Up to 3% of the global population has some form of psoriasis, a chronic inflammatory condition

- PMLiVE

Researchers’ new vaccine technology shows efficacy against broad range of coronaviruses

The vaccine provided protection against coronaviruses that have not yet emerged

- PMLiVE

Sobi’s Aspaveli receives expanded EC approval for rare blood disorder PNH

The C3 therapy can now be used as a first-line treatment for paroxysmal nocturnal haemoglobinuria

- PMLiVE

AstraZeneca begins global withdrawal of COVID-19 vaccine following decline in demand

The company applied to voluntarily withdraw its European marketing authorisation on 5 March

- PMLiVE

Novo Nordisk Foundation, Wellcome and Gates Foundation collaborate to accelerate global health equity

The collaboration will support solutions to address the health impacts of climate change, infectious diseases and AMR

- PMLiVE

Study reveals two copies of APOE4 gene could increase risk of developing Alzheimer’s

The progressive neurodegenerative disease is the most common form of dementia

- PMLiVE

Gilead Sciences appoints Peter Wickersham to vice-president and general manager in the UK and Ireland

Wickersham recently led Gilead’s liver disease and COVID-19 business unit in the US

- PMLiVE

Ignite the spark: empowering healthcare through digital therapeutics and innovative communication

By Rob Woods

Beyond-AI-Anxiety

Beyond the AI anxiety: The impact of human intuition

Explore the ways we're adapting to work with AI, not against it

Mednet Group

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links